BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations
出版年份 2015 全文链接
标题
BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations
作者
关键词
-
出版物
MODERN PATHOLOGY
Volume 28, Issue 8, Pages 1043-1057
出版商
Springer Nature
发表日期
2015-05-29
DOI
10.1038/modpathol.2015.65
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- High Incidence of Somatic BAP1 Alterations in Sporadic Malignant Mesothelioma
- (2015) Masaki Nasu et al. Journal of Thoracic Oncology
- p16 FISH Deletion in Surface Epithelial Mesothelial Proliferations Is Predictive of Underlying Invasive Mesothelioma
- (2014) Harry Hwang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Germline Mutation of Bap1 Accelerates Development of Asbestos-Induced Malignant Mesothelioma
- (2014) J. Xu et al. CANCER RESEARCH
- Whole-Exome Sequencing Reveals Frequent Genetic Alterations in BAP1, NF2, CDKN2A, and CUL1 in Malignant Pleural Mesothelioma
- (2014) G. Guo et al. CANCER RESEARCH
- Germline Mutations in BAP1 Impair Its Function in DNA Double-Strand Break Repair
- (2014) I. H. Ismail et al. CANCER RESEARCH
- Molecular Classification of Malignant Pleural Mesothelioma: Identification of a Poor Prognosis Subgroup Linked to the Epithelial-to-Mesenchymal Transition
- (2014) Aurélien de Reyniès et al. CLINICAL CANCER RESEARCH
- How useful is GLUT-1 in differentiating mesothelial hyperplasia and fibrosing pleuritis from epithelioid and sarcomatoid mesotheliomas? An international collaborative study
- (2014) Aliya N. Husain et al. LUNG CANCER
- Comparative Immunohistochemical Analysis of IMP3, GLUT1, EMA, CD146, and Desmin for Distinguishing Malignant Mesothelioma From Reactive Mesothelial Cells
- (2013) Hiroshi Minato et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma
- (2013) Richard W. Joseph et al. CANCER
- Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers
- (2013) Douglas W Henderson et al. JOURNAL OF CLINICAL PATHOLOGY
- Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA
- (2013) Douglas W Henderson et al. JOURNAL OF CLINICAL PATHOLOGY
- BAP1 Protein is a Progression Factor in Malignant Pleural Mesothelioma
- (2013) Lisa Arzt et al. PATHOLOGY & ONCOLOGY RESEARCH
- Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair
- (2013) H. Yu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Distinct Subset of Atypical Spitz Tumors is Characterized by BRAF Mutation and Loss of BAP1 Expression
- (2012) Thomas Wiesner et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- IMP3 and GLUT-1 Immunohistochemistry for Distinguishing Benign From Malignant Mesothelial Proliferations
- (2012) Anna F. Lee et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The Separation of Benign and Malignant Mesothelial Proliferations
- (2012) Andrew Churg et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Utility of Glucose Transporter 1 in the Distinction of Benign and Malignant Thoracic and Abdominal Mesothelial Lesions
- (2012) Stephen M. Lagana et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group
- (2012) Aliya N. Husain et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma
- (2012) Yoshie Yoshikawa et al. CANCER SCIENCE
- CD147 immunohistochemistry discriminates between reactive mesothelial cells and malignant mesothelioma
- (2012) Céline Pinheiro et al. DIAGNOSTIC CYTOPATHOLOGY
- Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update
- (2012) Nelson G. Ordóñez HUMAN PATHOLOGY
- BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
- (2012) Michele Carbone et al. Journal of Translational Medicine
- Expression and role of GLUT-1, MCT-1, and MCT-4 in malignant pleural mesothelioma
- (2012) Ai Mogi et al. VIRCHOWS ARCHIV
- The Diagnostic Utility ofp16FISH and GLUT-1 Immunohistochemical Analysis in Mesothelial Proliferations
- (2011) Sara E. Monaco et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Oncofetal Protein IMP3, a New Diagnostic Biomarker to Distinguish Malignant Mesothelioma From Reactive Mesothelial Proliferation
- (2011) Min Shi et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Importance of gender in diffuse malignant peritoneal mesothelioma
- (2011) C. Cao et al. ANNALS OF ONCOLOGY
- Pleural malignant mesothelioma epidemic: Incidence, modalities of asbestos exposure and occupations involved from the Italian National Register
- (2011) Alessandro Marinaccio et al. INTERNATIONAL JOURNAL OF CANCER
- The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
- (2011) Matthew Bott et al. NATURE GENETICS
- Germline mutations in BAP1 predispose to melanocytic tumors
- (2011) Thomas Wiesner et al. NATURE GENETICS
- The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions
- (2010) Farnaz Hasteh et al. CANCER CYTOPATHOLOGY
- Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry
- (2010) Xue-Ying Su et al. DIAGNOSTIC CYTOPATHOLOGY
- Diagnostic usefulness of EMA, IMP3, and GLUT-1 for the immunocytochemical distinction of malignant cells from reactive mesothelial cells in effusion cytology using cytospin preparations
- (2010) Katsuhide Ikeda et al. DIAGNOSTIC CYTOPATHOLOGY
- IMP3/L523S, a novel immunocytochemical marker that distinguishes benign and malignant cells: the expression profiles of IMP3/L523S in effusion cytology
- (2010) Katsuhide Ikeda et al. HUMAN PATHOLOGY
- Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium
- (2010) Ayuko Sato et al. MODERN PATHOLOGY
- Sarcomatoid mesothelioma: a clinical–pathologic correlation of 326 cases
- (2010) Sonja Klebe et al. MODERN PATHOLOGY
- The Ubiquitin Carboxyl Hydrolase BAP1 Forms a Ternary Complex with YY1 and HCF-1 and Is a Critical Regulator of Gene Expression
- (2010) H. Yu et al. MOLECULAR AND CELLULAR BIOLOGY
- 9p21 deletion in the diagnosis of malignant mesothelioma, using fluorescence in situ hybridization analysis
- (2010) Maiko Takeda et al. PATHOLOGY INTERNATIONAL
- Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
- (2010) J. W. Harbour et al. SCIENCE
- Usefulness of EMA, GLUT-1, and XIAP for the Cytologic Diagnosis of Malignant Mesothelioma in Body Cavity Fluids
- (2009) Jian Shen et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma
- (2009) Yukio Takeshima et al. HISTOPATHOLOGY
- Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage
- (2009) William Vermi et al. IMMUNOBIOLOGY
- The Deubiquitinating Enzyme BAP1 Regulates Cell Growth via Interaction with HCF-1
- (2009) Yuichi J. Machida et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- BRCA1-Associated Protein-1 Is a Tumor Suppressor that Requires Deubiquitinating Activity and Nuclear Localization
- (2008) K. H. Ventii et al. CANCER RESEARCH
- BRCA1-Associated Protein 1 Interferes with BRCA1/BARD1 RING Heterodimer Activity
- (2008) H. Nishikawa et al. CANCER RESEARCH
- Mesothelioma Epidemiology, Carcinogenesis, and Pathogenesis
- (2008) Haining Yang et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas
- (2008) Simion Chiosea et al. MODERN PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation